WO2025248492 - WISKOTT-ALDRICH SYNDROME BINDING PROTEINS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/248492
Publication Date
04.12.2025
International Application No.
PCT/IB2025/055585
International Filing Date
30.05.2025
Title **
[English]
WISKOTT-ALDRICH SYNDROME BINDING PROTEINS AND USES THEREOF
[French]
PROTÉINES DE LIAISON DU SYNDROME WISKOTT-ALDRICH ET LEURS UTILISATIONS
Applicants **
CSL BEHRING LLC
Inventors
HAMMET, Andrew Bruce
QUEK, Adam
Priority Data
63/653,347
30.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3912 | |
| EPO | Filing, Examination, Granting | 24313 | |
| Japan | Filing, Examination, Granting | 2604 | |
| South Korea | Filing, Examination, Granting | 3028 | |
| USA | Filing, Examination, Granting | 21260 |
Total:
55,117
Contact Us
Abstract[English]
The present disclosure relates to Wiskott-Aldrich Syndrome (WAS) binding proteins and uses thereof. The present disclosure further relates to WAS protein variants thereof and methods of producing WAS binding proteins thereof.[French]
La présente divulgation concerne des protéines de liaison du syndrome de Wiskott-Aldrich (WAS) et leurs utilisations. La présente divulgation concerne en outre des variants de protéine WAS associés et des procédés de production de protéines de liaison à WAS associées.